See All Slides - tctmd.com

Slides

Presentation TCT 2023

First-in-Human Experience with a Tricuspid Valve Flow Optimizer (TriFlow)

Presenter: Gorav Ailawadi

October 25, 2023

Presentation TCT 2023

TRILUMINATE Pivotal Imaging Substudy: Insights from CT and MRI

Presenter: Joao Cavalcante

October 25, 2023

Presentation TCT 2023

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

Presenter: Suzanne Arnold

October 25, 2023

Presentation TCT 2023

Wearable HF Monitoring Devices: Landscape Overview, Patient Indications, and Implementation Science

Presenter: Liviu Klein

October 25, 2023

Presentation TCT 2023

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: Navin Kapur

October 25, 2023

Presentation TCT 2023

Acute Decompensated HF Trials: Who Should be Enrolled and What Should the Study Endpoints Be?

Presenter: JoAnn Lindenfeld

October 25, 2023

Presentation TCT 2023

Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update

Presenter: Mehdi Shishehbor

October 25, 2023

Presentation TCT 2023

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

Presenter: Eric Secemsky

October 25, 2023

Presentation TCT 2023

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

Presenter: Gabor Toth

October 25, 2023

Presentation TCT 2023

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

Presenter: Nir Uriel

October 25, 2023

Advertisement

Slides

First-in-Human Experience with a Tricuspid Valve Flow Optimizer (TriFlow)

TRILUMINATE Pivotal Imaging Substudy: Insights from CT and MRI

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

Wearable HF Monitoring Devices: Landscape Overview, Patient Indications, and Implementation Science

The Conundrum of Clinical Trials in Cardiogenic Shock

Acute Decompensated HF Trials: Who Should be Enrolled and What Should the Study Endpoints Be?

Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content